Hot Courses

  • The ASAM Review Course in Addiction Medicine 2018 (20.5 CME)

    Contains 24 Product(s)

    Earn up to 20.5 CME while preparing for the ABPM Addiction Medicine Exam using this on-demand package of courses, containing the conference recordings, resources, practice questions, and slides from The ASAM Review Course in Addiction Medicine, 2018. The ASAM Review Course in Addiction Medicine is widely recognized as the essential primer for physicians and clinicians preparing for a career in addiction medicine, as well as for primary care providers who wish to increase their skills in identifying and managing patients whose medical problems are caused or exacerbated by substance use disorders.

    image

    Overview

    The ASAM Review Course in Addiction Medicine is widely recognized as the essential primer for physicians and clinicians preparing for a career in addiction medicine, as well as for primary care providers who wish to increase their skills in identifying and managing patients whose medical problems are caused or exacerbated by substance use disorders.

    The course offers two and a half days of sessions which are mapped to the addiction medicine exam blueprint of topics for the exam and features an outstanding faculty. Over 600 professionals attend this popular course each time it is offered. ASAM’s Review Course has had a major impact on advancing a common base of scientific knowledge among physicians and other healthcare professionals.

    Learning Objectives

    Upon completion, participants should be able to:

    1. Demonstrate practical knowledge on the neurobiology of addiction and articulate its activity in terms useful in a clinical setting
    2. Describe the effects of alcohol, tobacco and other drugs in both tolerant and non-tolerant individuals
    3. Describe the process for diagnosing addiction and differentiating the symptoms of addiction from those of other medical or psychiatric disorders
    4. Explain the various pharmacologic and psychosocial treatments for addictive disorders and describe the factors that should be considered in selecting a treatment modality to match the needs of a specific patient
    5. Describe the precipitants of relapse and current evidence-based practices to prevent and manage relapse

    Additional Resources

    Additional Board Exam Preparation resources and tools are also available.


    The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    The ASAM CME Committee and Reviewers Disclosure Listing

    First Name Commercial Interests Compensation Received For what Role?
    Timothy Brennan MD, MPH, FASAM None
    Jeffrey DeVido MD Altria/Philip Morris Stock Inheritance
    Paul Earley MD, DFASAM Alkermes, Inc; DynamiCare Health, Inc honoraria; Salary Speaker; VP of Medical Affairs 
    James Finch MD, DFASAM None

    Marc Fishman MD, DFASAM US World Meds; Alkermes consulting fee, travel; honoraria Consultant; Advisory board
    David Galbis-Reig MD, DFASAM Ascension Wisconsin All Saints; Abbvie; Hospira; RespireRX Pharmaceuticals; Abbott Pharmaceuticals; Pfizer Bond Stock& Bond in Retirement IRA; Stock Options; Ownership Interests  Owner; Advisory board; PI; Consultant
    Adam Gordon, MD, MPH None
    Leslie Hayes, MD None
    Abigail Herron DO, DFASAM None
    Petros Levounis MD, MA, FASAM None
    Carla Marienfeld MD None
    Ricardo Restrepo MD, MPH, FASAM None
    Richard Ries MD, DFASAM None
    Edwin Salsitz MD, DFASAM None
    Sharon Stancliff MD, FASAM None
    Timothy Wiegand MD, FACMT, FAACT None
    Erin Zerbo, MD None

    ACCME Accreditation Statement:

    The American Society of Addiction Medicine is accredited by the Accreditation Council for
    Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    AMA Credit Designation Statement:

    The American Society of Addiction Medicine designates this live activity for a maximum of 20.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    American Academy of Family Physicians: 

    This Live activity, The 2018 ASAM Review Course in Addiction Medicine & Pre-Courses, with a beginning date of 07/25/2018, has been reviewed and is acceptable for up to 27.50 Prescribed credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    ABAM Transitional Maintenance of Certification Program (Tmoc)

    This course has been approved by The American Board of Addiction Medicine (ABAM).  Physicians enrolled in the Transitional Maintenance of Certification (Tmoc) Program can apply a maximum of 20.5 AMA PRA Category 1 Credits

    American Psychological Association (APA)

    The American Society of Addiction Medicine (ASAM) Continuing Medical Education (CME) has been approved for renewal of certification by the APA College of Professional Psychology. ASAM CME credits may be applied toward the APA’s “Certificate of Proficiency in the Treatment of Alcohol and Other Psychoactive Substance Use Disorders.”

    Continuing Education Credits (CEUs)

    Non-physician participants will receive a certificate of attendance upon completion of the activity and an online evaluation confirming their participation. Participants should submit his/her certificate of attendance to their professional organization/institute.

    CME Committee Members

    • Catherine Friedman, MD, FASAM, Chair
    • R. Jeffrey Goldsmith, MD, DLFAPA, DFASAM
    • Adam J. Gordon, MD, MPH, FACP, DFASAM
    • Zwaantje Hamming, FNP-C, CARN-AP
    • Noel Ilogu, MD, MRCP, FASAM
    • Herbert L. Malinoff, MD, FACP, DFASAM
    • Edwin A. Salsitz, MD, DFASAM

    Staff - Sandy Metcalfe; Arlene Deverman, MA, CAE, CFRE; Marcia Jackson, PhD

    CME Committee, Program Planning Committee and Faculty Disclosure Information

    In accordance with the disclosure policies of the American Society of Addiction Medicine (ASAM) and the Accreditation Council for Continuing Medical Education (ACCME), the effort is made to ensure balance, independence, objectivity, and scientific rigor in all educational activities. These polices include resolving all conflicts of interest between the CME Committee, planning committee and faculty, and commercial interests that might otherwise compromise the goal and educational integrity of this activity. All planning committee members and faculty participating in the activity have disclosed all relevant financial relationships with commercial interests. The ASAM CME Committee has reviewed these disclosures and determined that the planning committee and faculty relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity.

    ACCME Accredited with Commendation

    ACCME Accreditation Statement

    The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    AMA Credit Designation Statement

    The American Society of Addiction Medicine designates this enduring material for a maximum of 20.5 AMA PRA Category 1 Credit(s).  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    ABPM Maintenance of Certification (MOC)

    The American Board of Preventive Medicine (ABPM) has approved this activity for a maximum of 20.5 LLSA credits towards ABPM MOC Part II requirements.

    ABAM Transitional Maintenance of Certification (tMOC)

    This course has been approved by the American Board of Addiction Medicine (ABAM). Physicians enrolled in the ABAM Transitional Maintenance of Certification Program (tMOC) can apply a maximum of 20.5 AMA PRA Category 1 Credit(s)™ for completing this course.

    Upon completion, participants should be able to:

    1. Demonstrate practical knowledge on the neurobiology of addiction and articulate its activity in terms useful in a clinical setting.
    2. Describe the effects of alcohol, tobacco and other drugs in both tolerant and non-tolerant individuals.
    3. Describe the process for diagnosing addiction and differentiating the symptoms of addiction from those of other medical or psychiatric disorders.
    4. Explain the various pharmacologic and psychosocial treatments for addictive disorders and describe the factors that should be considered in selecting a treatment modality to match the needs of a specific patient.
    5. Describe the precipitants of relapse and current evidence-based practices to prevent and manage relapse.

    The ASAM Review Course in Addiction Medicine provides an up-to-date review of the core content of addiction medicine for:

    • Physicians preparing for the ABPM Board Certification/Recertification Examination in addiction medicine
    • Addiction specialists seeking a "refresher" course that incorporates recent developments in addiction science and practice
    • Non-specialist physicians and other healthcare professionals needing the knowledge to identify and manage problems related to substance use disorders for their patients 
  • ASAM 49th Annual Conference - Innovations in Addiction Medicine and Science - 2018 (64.5 CME)

    Contains 49 Product(s)

    Earn a maximum of 64.5 AMA PRA Category 1™ credits while learning about the latest innovations in Addiction Medicine and Science from these on-demand conference recordings from the nation’s premiere conference on the latest science, research, best practices and innovations in addiction medicine.

    image

    Overview

    The ASAM 49th Annual Conference is the nation’s premiere conference on the latest science, research, best practices and innovations in addiction medicine. The 2018 program includes more education offerings such as; seven concurrent sessions offerings at a time instead of six, three pre-conference courses instead of two.  There will also be three Plenary Sessions that include the popular Opening Plenary Session and Policy Plenary Session and new this year the National Perspectives Plenary Session moderated by the ASAM president with leaders from national federal agencies. There will be other exciting changes to provide learning in a more interactive, casual and fun environment. 

    Learning Objectives

    At the conclusion of the conference, participants should be able to:

    • Identify and describe the new developments affecting the science, policy, and clinical practice of addiction medicine.
    • Compare presented clinical guidelines/best practices with the participant's current practice and identify strengths or gaps.
    • Analyze new research and science to develop practical applications for treatment or further research.
    • Explain recent or upcoming policy changes and identify implications or areas for provider involvement.
    • Create a network of professionals or a set of resources that can be used to support the participant's practice.


    Accreditation Council for Continuing Medical Education (ACCME)

    The American Society of Addiction Medicine (ASAM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. 

    The ASAM 49th Annual Conference - Innovations in Addiction Medicine and Science

    The American Society of Addiction Medicine designates this enduring material for a maximum of 64.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    ABAM Transitional Maintenance of Certification (Tmoc)

    This course has been approved by the American Board of Addiction Medicine (ABAM).  Physicians enrolled in the ABAM Transitional Maintenance of Certification (Tmoc) Program can apply a maximum of 64.5 AMA PRA Category 1 Credit(s)™ for completing the The ASAM 49th Annual Conference – Innovations in Addiction Medicine and Science.

    American Psychological Association (APA)

    The American Society of Addiction Medicine (ASAM) Continuing Medical Education (CME) has been approved for renewal of certification by the APA College of Professional Psychology. ASAM CME credits may be applied toward the APA’s “Certificate of Proficiency in the Treatment of Alcohol and Other Psychoactive Substance Use Disorders.”

    Continuing Education Credits (CEUs)

    Non-physician participants will receive a certificate of attendance upon completion of the activity and an online evaluation confirming their participation. Participants should submit his/her certificate of attendance to their professional organization/institute.

    CME Committee Members

    • Catherine Friedman, MD, FASAM, Chair
    • R. Jeffrey Goldsmith, MD, DLFAPA, DFASAM
    • Adam J. Gordon, MD, MPH, FACP, DFASAM
    • Zwaantje Hamming, FNP-C, CARN-AP
    • Noel Ilogu, MD, MRCP, FASAM
    • Herbert L. Malinoff, MD, FACP, DFASAM
    • Edwin A. Salsitz, MD, DFASAM

    Staff - Sandy Metcalfe; Arlene Deverman, MA, CAE, CFRE; Marica Jackson, PhD

    CME Committee, Program Planning Committee and Faculty Disclosure Information

    In accordance with the disclosure policies of the American Society of Addiction Medicine (ASAM) and the Accreditation Council for Continuing Medical Education (ACCME), the effort is made to ensure balance, independence, objectivity, and scientific rigor in all educational activities. These polices include resolving all conflicts of interest between the CME Committee, planning committee and faculty, and commercial interests that might otherwise compromise the goal and educational integrity of this activity. All planning committee members and faculty participating in the activity have disclosed all relevant financial relationships with commercial interests. The ASAM CME Committee has reviewed these disclosures and determined that the planning committee and faculty relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity.

    Who Should Attend:

    • Physicians and Clinicians
    • Researchers and Academics
    • Counselors and Students
    • Other Health Care Professionals 

    dedicated to increasing access and improving the quality of addiction treatment and care.

  • The ASAM Pain & Addiction: Common Threads XIX 2018 (8 CME)

    Contains 10 Product(s)

    Participants will learn clinical best practices and new research developments for treating patients with pain and addiction and how to begin to integrate these techniques into their own practices.

    OVERVIEW
    The ASAM Pain & Addiction: Common Threads Course is one of ASAM’s longest running and most popular courses. This course is designed to develop learners’ clinical skills and improve treatment of patients who fall somewhere in the gray area around pain and addiction. This course is designed for those in the addiction medicine field who already have some experience with pain and addiction.  

    This year’s course will address some of the most common barriers and challenges standing in the way of effective treatment and provide learners with skills or resources to immediately use in their practices. Presenters will address challenges such as appropriately assessing, diagnosing or treating patients (particularly those with psychiatric co-morbidities). Inaccurate diagnosis or referral can hinder treatment progress and impact patient trust in their health care providers. Presenters will also address complex, challenging patient cases such as patients on high doses of opioids or sedatives, patients with nicotine dependence, special patient populations, and many others. Lastly, presenters will review components of strong integrated practice settings and provide resources for learners to use in their own clinical practices. Many presentations will have a non-didactive component allowing participants to either self-reflect, review challenging cases, or engage with the presenters.

    LEARNING OBJECTIVES

    Upon completion, participants should be able to: 
    1. Distinguish between physiological dependence, substance use disorder, misuse, tolerance, and nonadherence in the context of pain.
    2. Use physical exams, functional assessments, screening tools, collateral information, and other tools in a clinical setting.
    3. Describe the interaction between pain, pain medication, addiction, and the patient’s emotional or psychological state. 
    4. Make appropriate treatment decisions for patients with pain, addiction, and psychiatric comorbidities.
    5. Explain the impacts of nicotine on pain treatment and develop methods for addressing nicotine use with patients.
    6. Manage the complex treatment needs of pregnant populations with pain and/or addiction.
    7. Direct or implement the medical management of withdrawal from opioids and other drugs.
    8. Evaluate the recent literature on benefits and limitations medication assisted treatment.
    9. Assess various practice models and create a plan for developing an integrated pain and addiction practice.

    This course is aimed toward addiction medicine specialists who treat patients with chronic pain and/or substance use disorders. Healthcare providers from other specialties who are interested in treating patients with chronic pain and addiction are also encouraged to attend.

    Upon completion, participants should be able to:

    1. Distinguish between physiological dependence, substance use disorder, misuse, tolerance, and nonadherence in the context of pain.
    2. Use physical exams, functional assessments, screening tools, collateral information, and other tools in a clinical setting.
    3. Describe the interaction between pain, pain medication, addiction, and the patient’s emotional or psychological state.
    4. Make appropriate treatment decisions for patients with pain, addiction, and psychiatric comorbidities.
    5. Explain the impacts of nicotine on pain treatment and develop methods for addressing nicotine use with patients.
    6. Manage the complex treatment needs of pregnant populations with pain and/or addiction.
    7. Direct or implement the medical management of withdrawal from opioids and other drugs.
    8. Evaluate the recent literature on benefits and limitations medication assisted treatment.
    9. Assess various practice models and create a plan for developing an integrated pain and addiction practice.

    ACCME Accredited with Commendation

    ACCME Accreditation Statement

    The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    AMA Credit Designation Statement

    The American Society of Addiction Medicine designates this enduring material for a maximum of 8 AMA PRA Category 1 Credit(s).  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    ABPM Maintenance of Certification (MOC)

    The American Board of Preventive Medicine (ABPM) has approved this activity for a maximum of 8 LLSA credits towards ABPM MOC Part II requirements.

    ABAM Transitional Maintenance of Certification (tMOC)

    This course has been approved by the American Board of Addiction Medicine (ABAM). Physicians enrolled in the ABAM Transitional Maintenance of Certification Program (tMOC) can apply a maximum of AMA PRA Category 1 Credit(s)™ for completing this course.

  • ASAM 48th Annual Conference - Innovations in Addiction Medicine and Science - 2017 (71 CME)

    Contains 57 Product(s)

    The nation’s premiere conference on the latest science, research, best practices and innovations in addiction medicine.

    The ASAM 48th Annual Conference is the nation’s premiere conference on the latest science, research, best practices and innovations in addiction medicine. The 2017 program includes more education offerings such as; seven concurrent sessions offerings at a time instead of six, three pre-conference courses instead of two.  There will also be three Plenary Sessions that include the popular Opening Plenary Session and Policy Plenary Session and new this year the National Perspectives Plenary Session moderated by the ASAM president with leaders from national federal agencies. There will be other exciting changes to provide learning in a more interactive, casual and fun environment. 

    Learning Objectives:

    At the conclusion of the conference, participants should be able to:

    • Identify and describe the new developments affecting the science, policy, and clinical practice of addiction medicine.
    • Compare presented clinical guidelines/best practices with the participant's current practice and identify strengths or gaps.
    • Analyze new research and science to develop practical applications for treatment or further research.
    • Explain recent or upcoming policy changes and identify implications or areas for provider involvement.
    • Create a network of professionals or a set of resources that can be used to support the participant's practice.


    Accreditation Council for Continuing Medical Education (ACCME)

    The American Society of Addiction Medicine (ASAM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. 

    The ASAM 48th Annual Conference - Innovations in Addiction Medicine and Science

    The American Society of Addiction Medicine designates this enduring material for a maximum of 71 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    ABAM Transitional Maintenance of Certification (Tmoc)

    This course has been approved by the American Board of Addiction Medicine (ABAM).  Physicians enrolled in the ABAM Transitional Maintenance of Certification (Tmoc) Program can apply a maximum of 71 AMA PRA Category 1 Credit(s)™ for completing the The ASAM 48th Annual Conference – Innovations in Addiction Medicine and Science.

    American Psychological Association (APA)

    The American Society of Addiction Medicine (ASAM) Continuing Medical Education (CME) has been approved for renewal of certification by the APA College of Professional Psychology. ASAM CME credits may be applied toward the APA’s “Certificate of Proficiency in the Treatment of Alcohol and Other Psychoactive Substance Use Disorders.”

    Continuing Education Credits (CEUs)

    Non-physician participants will receive a certificate of attendance upon completion of the activity and an online evaluation confirming their participation. Participants should submit his/her certificate of attendance to their professional organization/institute.

    CME Committee Members

    • Adam J. Gordon, MD, MPH, FACP, DFASAM, CMRO, Chair
    • Catherine Friedman, MD, FASAM, Vice-Chair
    • Noel Ilogu, MD, MRCP, FASAM
    • Herbert L. Malinoff, MD, FACP, DFASAM
    • Edwin A. Salsitz, MD, DFASAM
    • John C. Tanner, DO, CCFC, DFASAM

    Staff - Sandy Metcalfe, Consultant, ASAM CME Committee, Professional Development Department

    CME Committee, Program Planning Committee and Faculty Disclosure Information

    In accordance with the disclosure policies of the American Society of Addiction Medicine (ASAM) and the Accreditation Council for Continuing Medical Education (ACCME), the effort is made to ensure balance, independence, objectivity, and scientific rigor in all educational activities. These polices include resolving all conflicts of interest between the CME Committee, planning committee and faculty, and commercial interests that might otherwise compromise the goal and educational integrity of this activity. All planning committee members and faculty participating in the activity have disclosed all relevant financial relationships with commercial interests. The ASAM CME Committee has reviewed these disclosures and determined that the planning committee and faculty relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity.

    Who Should Attend:

    • Physicians and Clinicians
    • Researchers and Academics
    • Counselors and Students
    • Other Health Care Professionals 

    dedicated to increasing access and improving the quality of addiction treatment and care.

  • The ASAM Pain & Addiction: Common Threads Course XVIII 2017 (7.5 CME)

    Contains 5 Product(s)

    Participants will have the opportunity to learn about the new research and clinical guidelines on treating patients with pain and addiction and how to apply these to improve patient outcomes.

    The theme for the 18th year of The ASAM Pain & Addiction: Common Threads Course is There and Back Again. In the past couple years, research and clinical guidelines for treating patients with pain and/or addiction have evolved dramatically, challenging the traditional way providers think about pain and addiction. Experts in the field will review the scientific, legislative, and clinical updates from the recent months and examine how these updates will affect the methods providers use to treat their patients. Presenters will also address how the “traditional” pain and addiction provider has changed and how to get providers from diverse backgrounds on the same page for patient care. Participants will learn about the many paradigm-shifting updates to the field through a series of mini-lectures. Participants will discuss ways to apply these changes to their practices with a rousing afternoon discussion with peers. Course attendees will leave the course with new knowledge and an understanding that can be immediately applied to their clinical practice.

    This course is aimed toward healthcare providers, at any level, who see patients with chronic pain and substance use disorders. Provider specialties can include, but are not limited to: addiction medicine, pain medicine, emergency medicine, internal medicine, anesthesiology, and psychiatry. 

    Upon completion, participants should be able to: 

    1. Identify and describe the new developments affecting the science, policy, and clinical practice of pain and addiction. 

    2. Analyze new research and science to develop practical applications for treatment or further research. 

    3. Evaluate their current practice, while considering new recommendations/best practices to recognize strengths or gaps. 

    4. Find and use apps, websites, or other resources to support their practice or their patient’s treatment. 

    5. Assess their feelings and attitudes towards the treatment of patients with pain and addiction. 

    Accreditation Council for Continuing Medical Education (ACCME)

    The American Society of Addiction Medicine (ASAM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. 

    The ASAM Pain & Addiction: Common Threads Course XVIII

    The American Society of Addiction Medicine designates this enduring material for a maximum of 7.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    ABAM Transitional Maintenance of Certification (Tmoc)

    This course has been approved by the American Board of Addiction Medicine (ABAM).  Physicians enrolled in the ABAM Transitional Maintenance of Certification (Tmoc) Program can apply a maximum of 7.5 AMA PRA Category 1 Credit(s)™ for completing the The ASAM Pain & Addiction: Common Threads Course XVIII.

    American Psychological Association (APA)

    The American Society of Addiction Medicine (ASAM) Continuing Medical Education (CME) has been approved for renewal of certification by the APA College of Professional Psychology. ASAM CME credits may be applied toward the APA’s “Certificate of Proficiency in the Treatment of Alcohol and Other Psychoactive Substance Use Disorders.”

    Continuing Education Credits (CEUs)

    Non-physician participants will receive a certificate of attendance upon completion of the activity and an online evaluation confirming their participation. Participants should submit his/her certificate of attendance to their professional organization/institute.

    CME Committee Members

    • Adam J. Gordon, MD, MPH, FACP, DFASAM, CMRO, Chair
    • Catherine Friedman, MD, FASAM, Vice-Chair
    • Noel Ilogu, MD, MRCP, FASAM
    • Herbert L. Malinoff, MD, FACP, DFASAM
    • Edwin A. Salsitz, MD, DFASAM
    • John C. Tanner, DO, CCFC, DFASAM

    Staff - Sandy Metcalfe, Consultant, ASAM CME Committee, Professional Development Department

    CME Committee, Program Planning Committee and Faculty Disclosure Information

    In accordance with the disclosure policies of the American Society of Addiction Medicine (ASAM) and the Accreditation Council for Continuing Medical Education (ACCME), the effort is made to ensure balance, independence, objectivity, and scientific rigor in all educational activities. These polices include resolving all conflicts of interest between the CME Committee, planning committee and faculty, and commercial interests that might otherwise compromise the goal and educational integrity of this activity. All planning committee members and faculty participating in the activity have disclosed all relevant financial relationships with commercial interests. The ASAM CME Committee has reviewed these disclosures and determined that the planning committee and faculty relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity.

    ASAM Pain & Addiction Pre-Conference Course Faculty

    Name

    Disclosure

    Andrea Barthwell, MD, DFASAM

    Alere (not current); Apple Tree Life Sciences; Braeburn Pharmaceuticals (not current); Encounter Medical Group, P.C.; Ideal Option; The Manor (not current); Millennium Health (not current); Two Dreams; U.S. DOJ

    Marla Golden, DO, FACEP

    No Financial Relationships or Conflicts of Interest

    William F. Haning, III, MD, DFASAM, DFAPA

    No Financial Relationships or Conflicts of Interest

    William S. Jacobs, MD

    No Financial Relationships or Conflicts of Interest

    Andrew J. Kolodny, MD, FASAM

    No Financial Relationships or Conflicts of Interest

    Laura Morgan, PharmD

    No Financial Relationships or Conflicts of Interest

    Mark Pew

    No Financial Relationships or Conflicts of Interest

    Melvin I. Pohl, MD, DFASAM

    No Financial Relationships or Conflicts of Interest

    Ilene Robeck MD, FASAM

    No Financial Relationships or Conflicts of Interest

    Mark Seltzer, JD

    No Financial Relationships or Conflicts of Interest

    Michael P. Sprintz, DO, FASAM

    Cellarian Health, LLC Equity, CEO; Endo Pharmaceuticals, Honorarium, Chronic Pain Advisory Board Member

    Corey Waller, MD, MS, DFASAM

    No Financial Relationships or Conflicts of Interest

    Alexander Walley, MD, FASAM

    No Financial Relationships or Conflicts of Interest

    Mark Weiner, MD, DFASAM

    No Financial Relationships or Conflicts of Interest

     

    ASAM Pain & Addiction Pre-Conference Course Planning Committee

     

    Name

    Disclosure

    Mark Weiner, MD, DFASAM (Chair)

    No Financial Relationships or Conflicts of Interest

    Corey Waller, MD, MS, DFASAM

    No Financial Relationships or Conflicts of Interest

    William S. Jacobs, MD

    No Financial Relationships or Conflicts of Interest

    Laura Morgan, PharmD

    No Financial Relationships or Conflicts of Interest

    Melvin I. Pohl, MD, DFASAM

    No Financial Relationships or Conflicts of Interest

    Ilene Robeck MD, FASAM

    No Financial Relationships or Conflicts of Interest

    Michael P. Sprintz, DO, FASAM

    Cellarian Health, LLC Equity, CEO; Endo Pharmaceuticals, Honorarium, Chronic Pain Advisory Board Member

    Name

    Disclosure

    Adam J. Gordon, MD, MPH, FACP, DFASAM, CMRO, Chair

    No Financial Relationships or Conflicts of Interest

    Catherine Friedman, MD

    No Financial Relationships or Conflicts of Interest

    Noel Ilogu, MD, MRCP, DFASAM

    No Financial Relationships or Conflicts of Interest

    Herbert L. Malinoff, MD, FACP, DFASAM

    No Financial Relationships or Conflicts of Interest

    Edwin A. Salsitz, MD, DFASAM

    No Financial Relationships or Conflicts of Interest

    John C. Tanner, DO, DABAM, DFASAM, CCFC, MRO

    Indivior, Honorarium, Speaker; BDSI, Honorarium, Consultant/Speaker